Piper Sandler Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $85
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
Piper Sandler analyst David Westenberg initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Overweight rating and announces Price Target of $85.
Piper Sandler analyst David Westenberg initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Overweight rating and announces Price Target of $85.